Savara Pharmaceuticals Company Profile

Aggregated data from the web about Savara Pharmaceuticals

Company Name	Savara Pharmaceuticals
Website	https://savarapharma.com
Snippet	Clinical trials. Savara is currently conducting a pivotal Phase 3 clinical trial, IMPALA, of Molgradex for the treatment of autoimmune pulmonary alveolar proteinosis (aPAP), IMPALA-X, an open-label, safety extension study in aPAP, and a Phase 2a clinical study, OPTIMA, of Molgradex for the treatment of nontuberculous mycobacterial (NTM) infection.
Country	united states
Founded	2007.0
Website	savarapharma.com
Industry	pharmaceuticals
linkedin	linkedin.com/company/savara-pharmaceuticals
size_range	11 - 50
display_url	savarapharma.com
Headquarters	austin, texas, united states
Number of employees	18

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.